JP Morgan Maintains Neutral on Nevro, Lowers Price Target to $28
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Robbie Marcus has maintained a Neutral rating on Nevro (NYSE:NVRO) and lowered the price target from $40 to $28.
June 28, 2023 | 12:51 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan has maintained a Neutral rating on Nevro and lowered the price target from $40 to $28.
The lowering of the price target by JP Morgan indicates a less optimistic outlook for the company's stock, which could potentially lead to a decrease in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100